Cleared Abbreviated

K140258 - IMMULITE 2000 DHEA-SO4

Also marketed or referenced as:
THIRD GENERATION TSH AND INTACT PTH CALIBRATION VERIFICATION MATERIAL

K140258 is an FDA 510(k) clearance for IMMULITE 2000 DHEA-SO4, manufactured by Siemens Healthcare Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Abbreviated 510(k) pathway after a 30-day FDA review.

K140258 · Siemens Healthcare Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
30d
Days
Class 1
Risk

K140258 is an FDA 510(k) clearance for the IMMULITE 2000 DHEA-SO4. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on March 5, 2014 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Siemens Healthcare Diagnostics, Inc. devices

FDA 510(k) Submission Details - K140258

510(k) Number K140258 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 03, 2014
Decision Date March 05, 2014
Days to Decision 30 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 88d · This submission: 30d
Pathway characteristics
Standards-based clearance path.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 402
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K140258.
ADVIA CENTAUR VITAMIN B12 MASTER CURVE MATERIAL, TOTAL HCG MASTER CURVE MATERIAL, AND TESTOSTERONE MASTER CURVE MATERIAL
K140505 · Siemens Healthcare Diagnostics, Inc. · Mar 2014
ELECSYS PRECICONTROL TS
K140534 · Roche Diagnostics · Mar 2014
ADVIA CENTAUR TNI-ULTRA MASTER CURVE MATERIAL (MCM), ADVIA CENTAUR DIGOXIN MASTER CURVE MATERIAL (MCM)
K140267 · Siemens Healthcare Diagnostics, Inc. · Mar 2014
FDI LEVEL I AND LEVEL II GLUCOSE CONTROLS FOR THE EMBRACE NO CODE
K133197 · Fujirebio Diagnostics,Inc. · Jan 2014
IMMULITE 2000 AFP, BR-MA, AND OM-MA CALIBRATION VERIFICATION MATERIAL
K132739 · Siemens Healthcare Diagnostics, Inc. · Jan 2014
ELECSYS CK-MB CALCHECK 5
K133284 · Roche Diagnostics · Nov 2013